European Commission authorizes Pfizer vaccine adapted to XFG variant

The European Commission approves the Pfizer-BioNTech vaccine targeting the XFG variant of Covid-19.

Published 3h1 sourceImportant

≈ 17sSpeed

The fact

This authorization follows evaluation by the European Medicines Agency.

Booster campaigns will be able to include this vaccine starting autumn 2026.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 14, 2026